Target Reported an Earnings Beat and Reata Pharmaceuticals Received Good News from the FDA 💊

Table of Contents

Target Reported an Earnings Beat and Reata Pharmaceuticals Received Good News from the FDA

Target  

Target is one of the major retailers in the United States, competing with companies like Walmart and even Amazon. They have a market cap of $108.973 billion, and they offer a healthy dividend yield of 1.32%.

On Wednesday morning, Target reported some strong earnings. They announced a profit of $3.69 per share, crushing estimates, and their revenue number was $24.2 billion, which slightly beat expectations. Target said in their earnings call that increased vaccinations and state reopening’s have fueled their quarter, which has been the case for many retailers this week.

Even with the market selling off on Wednesday, Target went up 6.09% to $219.01.

Reata Pharmaceuticals

Reata Pharmaceuticals is a biotech company based in Plano, Texas. Unlike many biotechs, Reata is not a micro or small cap company with a market capitalization of $3.723 billion, and they aren’t as volatile.

On Wednesday, Reata received some positive news from the FDA for their drug, omaveloxolone. The drug is meant to treat a genetic disease that often leaves people with impaired speech and trouble walking, which is a major problem. The FDA announced a meeting with the company to consider sending the drug through the approval process, encouraging many investors. The disease Reata is targeting has no cure now, which provides a great opportunity for the company if they can get approval.

Reata stock reacted very positively, with the stock rising 23.78% to $102.63.

I am not a financial advisor and my comments should never be taken as financial advice. Investments come with risk, so always do your research and analysis beforehand.

Share:
More Posts
PGA Tour Enters Investment Talks 💪
29 September, 2023

As reported on Thursday, both Endeavor Group and Fenway Sports have displayed interest and begun discussions to provide investment in the PGA Tour.
Nike Just Didn’t Do It 📉
29 September, 2023

Providing one of the biggest earnings reports of the week, $140 billion shoe and clothing retailer Nike posted a significant slip.
Market Recap – September 28th 💰
29 September, 2023

After the 10-year Treasury yield bond fell off from its 15-year high, investors added some value back into the market, focusing all short-term attention on Friday’s PCE price index reading.
The Crude Oil Bust 🛢
28 September, 2023

Surging global crude oil prices, driven by factors like OPEC+ production cuts have pushed U.S. West Texas Intermediate futures to over $95 per barrel.

Load More
Get your daily Invstr Crunch

Get the market news and updates you need, delivered to your inbox or available on our daily podcast.

Facebook Twitter Youtube Instagram Snapchat Tiktok
learn
products
plan
Who we are
blog

Risk Disclosure:

Invstr is not a bank and banking services are provided by Vast Bank, N.A.

Brokerage and Banking services are currently only available to U.S. residents.

Invstr app and web services are provided by Invstr Ltd. Advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC) details of which can be obtained here. Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value.

Investing involves risk and can lead to losses. Past performance does not guarantee future results.

Invstr app and web services are provided by Invstr Ltd. Invstr+ advisory services are provided by Invstr Financial LLC, an investment adviser registered with the Securities Exchange Commission (SEC). Securities brokerage and custody services are provided by Apex Clearing, a broker dealer registered with the SEC and a member of FINRA and SIPC. There is no bank guarantee on securities and securities may lose value. Vast Bank N.A. a nationally chartered bank and member of the FDIC, provides the banking products, including the products and services related to digital asset accounts. As with any asset, the value of Digital assets can go up or down and there can be a substantial risk that you lose money buying or holding digital assets. You should carefully consider whether trading or holding Digital assets is suitable for you in light of your financial condition. Your digital account does not support wallet to wallet transferring of your digital assets (i.e. cryptocurrencies) outside the platform. Any Digital Assets in your digital asset account are not insured by any government entities, including but not limited to FDIC or SIPC. The Invstr Visa® Debit Card is issued by Vast Bank, N.A. pursuant to a license from Visa U.S.A Inc and may be used everywhere Visa debit cards are accepted. Invstr Ltd, Invstr Financial LLC and Invstr Securities Ltd are subsidiaries of Marketspringpad Holdings (collectively “Invstr”) and Invstr is solely responsible for the application services and website content.

Watchlists provided when users first access the service are not a recommendation to invest. Instead they are provided to help users better navigate the service. Users are free to edit and create their own watchlists. From time to time, Invstr will suggest instruments solely based on an individual’s interest and the interest levels of the Invstr community. The statistical and portfolio builder models generated by Invstr do not reflect actual investment results and are not guarantees of future results. Comments provided by Invstr leaders, influencers or members of the Invstr Community are not recommendations and should not be construed as such. Invstr does not endorse the content or the positions posted by them. Their investment approach, and that of the models provided by Invstr, may be different from yours and may not be appropriate for you.